Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment

About this Attention Score

• In the top 25% of all research outputs scored by Altmetric
• Good Attention Score compared to outputs of the same age (76th percentile)
• High Attention Score compared to outputs of the same age and source (93rd percentile)